NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

27 hedge funds and large institutions have $392K invested in Navidea Biopharmaceuticals Inc. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 23 reducing their positions, and 25 closing their positions.

Holders
27
Holders Change
-22
Holders Change %
-44.9%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
23
Closed
25
Calls
–
Puts
$14K
Net Calls
-$14K
Net Calls Change
-$15K

Top Buyers

1
WS
1
Wedbush Securities
California
$56K
2
VF
2
Virtu Financial
New York
$41K
3
Jane Street
3
Jane Street
New York
$12K
4
HighTower Advisors
4
HighTower Advisors
Illinois
$5K
5
ACM
5
Allred Capital Management
Texas
$11K

Top Sellers

1
Bank of New York Mellon
1
Bank of New York Mellon
New York
$0
2
Cambridge Investment Research Advisors
2
Cambridge Investment Research Advisors
Iowa
$0
3
Creative Planning
3
Creative Planning
Kansas
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$114K
5
State Street
5
State Street
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
51
Simplex Trading
Illinois
– – -100 Closed
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
– – – –
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
VFA
54
Valeo Financial Advisors
Indiana
$0 20 +20 New
1 2
3